These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Two microbiological relapses in a patient with lepromatous leprosy. Chakma JK, Girdhar A, Natrajan M, Kumar A, Girdhar BK. Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984 [Abstract] [Full Text] [Related]
5. Leprosy pseudoimbricata: an unusual presentation of steroid-modified borderline lepromatous leprosy. Kumar S, Mehta H, Aggarwal D, Chatterjee D, Narang T, Dogra S. Int J Dermatol; 2020 Apr; 59(4):e124-e125. PubMed ID: 31957882 [No Abstract] [Full Text] [Related]
8. Effect of chemotherapy on viability of Mycobacterium leprae as determined by ATP content, morphological index and FDA-EB fluorescent staining. Katoch VM, Katoch K, Ramanathan U, Sharma VD, Shivannavar CT, Datta AK, Bharadwaj VP. Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):615-21. PubMed ID: 2476522 [Abstract] [Full Text] [Related]
10. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients. Roche PW, Britton WJ, Neupane KD, Failbus SS, Cho SN, Theuvenet WJ. Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971 [Abstract] [Full Text] [Related]
11. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy. Narang T, Kaur I, Kumar B, Radotra BD, Dogra S. Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653 [Abstract] [Full Text] [Related]
12. Clinical and bacteriological progress of highly bacillated BL-LL patients discontinuing treatment after different periods of MDT. Katoch K, Natarajan M, Bagga A, Katoch VM. Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):248-54. PubMed ID: 2071982 [Abstract] [Full Text] [Related]
13. Pathologic changes in a tibial nerve with surviving M. leprae in a healed tuberculoid leprosy patient. Job CK, Baskaran B, Jayakumar J, Aschhoff M. Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):90-4. PubMed ID: 9207758 [Abstract] [Full Text] [Related]
14. A bacteriological assessment of multibacillary cases in leprosy colonies after 4 1/2 years of multidrug therapy. Naik SS, Bhanage ND, Sawant KV, Ganapati R. Indian J Lepr; 1988 Jul; 60(3):393-9. PubMed ID: 3058827 [Abstract] [Full Text] [Related]
15. The relapse rate in MB leprosy patients treated with 2-years of WHO-MDT is not low. Gelber RH, Balagon VF, Cellona RV. Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):493-500. PubMed ID: 15755209 [Abstract] [Full Text] [Related]
20. Daily multidrug therapy for leprosy; results of a fourteen-year experience. de Carsalade GY, Wallach D, Spindler E, Pennec J, Cottenot F, Flageul B. Int J Lepr Other Mycobact Dis; 1997 Mar 15; 65(1):37-44. PubMed ID: 9207752 [Abstract] [Full Text] [Related] Page: [Next] [New Search]